{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-1442"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-1442","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"Cytoanalysis of Pancreatic B-cells: Using an Avian Model, Mammalian Tissue Culture and Implications of Antisense Oligonucleotides Transfection","abstract":"Calbindin-D28k (CaBP28K) is a vitamin D-dependent calcium-binding protein that may alter intracellular calcium ion levels, [Ca2+]i. This dissertation describes experiments done to gain an understanding of the potential role of CaBP28k in pancreatic B-cells in control of insulin secretion. The localization of CaBP28k and insulin in chicken pancreas are shown in Chapter 1. CaBP28k expression was found to be highest in ventral and dorsal lobes and lowest in splenic lobe. Insulin concentrations were distributed similarly among these lobes. Confocal microscopic studies demonstrated colocalization of insulin and CaBP28k in Bcells. These findings suggest a possible role for CaBP28k in chicken B-cells that could contribute to type 2 diabetes-like characteristics of chickens. Experiments done in Chapter 2 tested the effects of changing levels of glucose in pancreatic islets in vitro from transgenically derived CaBP28k-knockout (KO) and wildtype (WT) mice. CaBP28k-KO islets were exposed to increasing glucose concentrations from 2.8 mM to 30 mM, levels that mimic transition from fasting to hyperglycemic states. KO islets showed significantly greater elevations in [Ca2+]i as compared to WT. These experiments provide evidence that levels of CaBP28k could play a role in controlling Ca2+-mediated, glucose-induced insulin secretion in B-cells. In chapter 3 the effects of reduction of CaBP28k levels on genomic and nongenomic factors using CaBP28k-antisense oligonucleotides (AS-ON) transfection in a cultured pancreatic B-cell line (RIN1046-38 cells) are described. Complete inhibition of CaBP28k expression in transfection assays was achieved using 200 nM phosphorothioate-AS-ON (PS-AS-ON) as well as 20 nM propyne-AS-ON (PY-AS-ON). In addition, cDNA microarray analysis showed up-regulation of both vitamin D receptor (VDR) and calbindin-D9k mRNAs in PS-AS-ON-transfected RIN cells as compared to controls. Western blotting indicated VDR overexpression and calbindin-D9k expression in AS-ON-transfected cells. This study is the first demonstration of compensatory expression of calbindin-D9k in response to inhibition of CaBP28k in cultured B-cells. Insulin secretory responses of PS-AS-ON-transfected cells were greater than in controls. These findings suggest that B-cells synthesize an alternative protein, calbindin-D9k, to preserve calcium regulation when expression of CaBP28k is abolished. Additional studies are required to help in understanding possible interactions of calbindin-D9k, [Ca2+]i, and VDR in the AS-ON-transfected B-cells.","abstract_html":"Calbindin-D28k (CaBP28K) is a vitamin D-dependent calcium-binding protein that may alter intracellular calcium ion levels, [Ca2+]i. This dissertation describes experiments done to gain an understanding of the potential role of CaBP28k in pancreatic B-cells in control of insulin secretion. The localization of CaBP28k and insulin in chicken pancreas are shown in Chapter 1. CaBP28k expression was found to be highest in ventral and dorsal lobes and lowest in splenic lobe. Insulin concentrations were distributed similarly among these lobes. Confocal microscopic studies demonstrated colocalization of insulin and CaBP28k in Bcells. These findings suggest a possible role for CaBP28k in chicken B-cells that could contribute to type 2 diabetes-like characteristics of chickens. Experiments done in Chapter 2 tested the effects of changing levels of glucose in pancreatic islets in vitro from transgenically derived CaBP28k-knockout (KO) and wildtype (WT) mice. CaBP28k-KO islets were exposed to increasing glucose concentrations from 2.8 mM to 30 mM, levels that mimic transition from fasting to hyperglycemic states. KO islets showed significantly greater elevations in [Ca2+]i as compared to WT. These experiments provide evidence that levels of CaBP28k could play a role in controlling Ca2+-mediated, glucose-induced insulin secretion in B-cells. In chapter 3 the effects of reduction of CaBP28k levels on genomic and nongenomic factors using CaBP28k-antisense oligonucleotides (AS-ON) transfection in a cultured pancreatic B-cell line (RIN1046-38 cells) are described. Complete inhibition of CaBP28k expression in transfection assays was achieved using 200 nM phosphorothioate-AS-ON (PS-AS-ON) as well as 20 nM propyne-AS-ON (PY-AS-ON). In addition, cDNA microarray analysis showed up-regulation of both vitamin D receptor (VDR) and calbindin-D9k mRNAs in PS-AS-ON-transfected RIN cells as compared to controls. Western blotting indicated VDR overexpression and calbindin-D9k expression in AS-ON-transfected cells. This study is the first demonstration of compensatory expression of calbindin-D9k in response to inhibition of CaBP28k in cultured B-cells. Insulin secretory responses of PS-AS-ON-transfected cells were greater than in controls. These findings suggest that B-cells synthesize an alternative protein, calbindin-D9k, to preserve calcium regulation when expression of CaBP28k is abolished. Additional studies are required to help in understanding possible interactions of calbindin-D9k, [Ca2+]i, and VDR in the AS-ON-transfected B-cells.","abstract_has_math":false,"creators":["Amer, Ayman Salah-el-deen"],"institution":null,"degree_name":"Biomedical Sciences","degree_level":"Dissertation","degree_discipline":"Joan C. Edwards School of Medicine","degree_department":null,"school":null,"contributors":["William B. Rhoten","Todd L. Green","William D. McCumbee"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:56:13Z","subjects":["Biological Phenomena, Cell Phenomena, and Immunity","Genetic Processes","Genetic Structures","Medical Sciences","Medicine and Health Sciences"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/442","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/442","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-1442","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["William B. Rhoten","Todd L. Green","William D. McCumbee"]},{"key":"dc:creator","label":"Author","values":["Amer, Ayman Salah-el-deen"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2013-04-10T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2004-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Joan C. Edwards School of Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biomedical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biological Phenomena, Cell Phenomena, and Immunity","Genetic Processes","Genetic Structures","Medical Sciences","Medicine and Health Sciences"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/442"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Calbindin-D28k (CaBP28K) is a vitamin D-dependent calcium-binding protein that may alter intracellular calcium ion levels, [Ca2+]i. This dissertation describes experiments done to gain an understanding of the potential role of CaBP28k in pancreatic B-cells in control of insulin secretion. The localization of CaBP28k and insulin in chicken pancreas are shown in Chapter 1. CaBP28k expression was found to be highest in ventral and dorsal lobes and lowest in splenic lobe. Insulin concentrations were distributed similarly among these lobes. Confocal microscopic studies demonstrated colocalization of insulin and CaBP28k in Bcells. These findings suggest a possible role for CaBP28k in chicken B-cells that could contribute to type 2 diabetes-like characteristics of chickens. Experiments done in Chapter 2 tested the effects of changing levels of glucose in pancreatic islets in vitro from transgenically derived CaBP28k-knockout (KO) and wildtype (WT) mice. CaBP28k-KO islets were exposed to increasing glucose concentrations from 2.8 mM to 30 mM, levels that mimic transition from fasting to hyperglycemic states. KO islets showed significantly greater elevations in [Ca2+]i as compared to WT. These experiments provide evidence that levels of CaBP28k could play a role in controlling Ca2+-mediated, glucose-induced insulin secretion in B-cells. In chapter 3 the effects of reduction of CaBP28k levels on genomic and nongenomic factors using CaBP28k-antisense oligonucleotides (AS-ON) transfection in a cultured pancreatic B-cell line (RIN1046-38 cells) are described. Complete inhibition of CaBP28k expression in transfection assays was achieved using 200 nM phosphorothioate-AS-ON (PS-AS-ON) as well as 20 nM propyne-AS-ON (PY-AS-ON). In addition, cDNA microarray analysis showed up-regulation of both vitamin D receptor (VDR) and calbindin-D9k mRNAs in PS-AS-ON-transfected RIN cells as compared to controls. Western blotting indicated VDR overexpression and calbindin-D9k expression in AS-ON-transfected cells. This study is the first demonstration of compensatory expression of calbindin-D9k in response to inhibition of CaBP28k in cultured B-cells. Insulin secretory responses of PS-AS-ON-transfected cells were greater than in controls. These findings suggest that B-cells synthesize an alternative protein, calbindin-D9k, to preserve calcium regulation when expression of CaBP28k is abolished. Additional studies are required to help in understanding possible interactions of calbindin-D9k, [Ca2+]i, and VDR in the AS-ON-transfected B-cells."]},{"key":"dc:title","label":"Title","values":["Cytoanalysis of Pancreatic B-cells: Using an Avian Model, Mammalian Tissue Culture and Implications of Antisense Oligonucleotides Transfection"]}]}],"canonical_facts":{"dc:contributor":["William B. Rhoten","Todd L. Green","William D. McCumbee"],"dc:creator":["Amer, Ayman Salah-el-deen"],"dc:date.available":["2013-04-10T07:00:00Z"],"dc:date.created":["2004-01-01T08:00:00Z"],"dc:description.abstract":["Calbindin-D28k (CaBP28K) is a vitamin D-dependent calcium-binding protein that may alter intracellular calcium ion levels, [Ca2+]i. This dissertation describes experiments done to gain an understanding of the potential role of CaBP28k in pancreatic B-cells in control of insulin secretion. The localization of CaBP28k and insulin in chicken pancreas are shown in Chapter 1. CaBP28k expression was found to be highest in ventral and dorsal lobes and lowest in splenic lobe. Insulin concentrations were distributed similarly among these lobes. Confocal microscopic studies demonstrated colocalization of insulin and CaBP28k in Bcells. These findings suggest a possible role for CaBP28k in chicken B-cells that could contribute to type 2 diabetes-like characteristics of chickens. Experiments done in Chapter 2 tested the effects of changing levels of glucose in pancreatic islets in vitro from transgenically derived CaBP28k-knockout (KO) and wildtype (WT) mice. CaBP28k-KO islets were exposed to increasing glucose concentrations from 2.8 mM to 30 mM, levels that mimic transition from fasting to hyperglycemic states. KO islets showed significantly greater elevations in [Ca2+]i as compared to WT. These experiments provide evidence that levels of CaBP28k could play a role in controlling Ca2+-mediated, glucose-induced insulin secretion in B-cells. In chapter 3 the effects of reduction of CaBP28k levels on genomic and nongenomic factors using CaBP28k-antisense oligonucleotides (AS-ON) transfection in a cultured pancreatic B-cell line (RIN1046-38 cells) are described. Complete inhibition of CaBP28k expression in transfection assays was achieved using 200 nM phosphorothioate-AS-ON (PS-AS-ON) as well as 20 nM propyne-AS-ON (PY-AS-ON). In addition, cDNA microarray analysis showed up-regulation of both vitamin D receptor (VDR) and calbindin-D9k mRNAs in PS-AS-ON-transfected RIN cells as compared to controls. Western blotting indicated VDR overexpression and calbindin-D9k expression in AS-ON-transfected cells. This study is the first demonstration of compensatory expression of calbindin-D9k in response to inhibition of CaBP28k in cultured B-cells. Insulin secretory responses of PS-AS-ON-transfected cells were greater than in controls. These findings suggest that B-cells synthesize an alternative protein, calbindin-D9k, to preserve calcium regulation when expression of CaBP28k is abolished. Additional studies are required to help in understanding possible interactions of calbindin-D9k, [Ca2+]i, and VDR in the AS-ON-transfected B-cells."],"dc:identifier":["https://mds.marshall.edu/etd/442"],"dc:subject":["Biological Phenomena, Cell Phenomena, and Immunity","Genetic Processes","Genetic Structures","Medical Sciences","Medicine and Health Sciences"],"dc:title":["Cytoanalysis of Pancreatic B-cells: Using an Avian Model, Mammalian Tissue Culture and Implications of Antisense Oligonucleotides Transfection"],"thesis:degree_discipline":["Joan C. Edwards School of Medicine"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Biomedical Sciences"]},"updated_at":"2026-11-21T19:56:13Z"}